Compound Detail
CHEMBL4564045
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4564045 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NPXSYQBDXAAEFW-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
465.6
MW (Da)
3.10
ALogP
8
HBA
2
HBD
89.6
PSA (Ų)
0.61
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.17
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HepG2 CHEMBL395 | IC50 | 5.17 | 5.17 | 6700.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 6700.0 | nM | 5.17 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 31238183 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31238183 | 10.1016/j.ejmech.2019.06.024 | CDK2/Cyclin A2 | 1 |
| 31238183 | 10.1016/j.ejmech.2019.06.024 | CDK9/cyclin T1 | 1 |
| 31238183 | 10.1016/j.ejmech.2019.06.024 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine